NCT02887599 Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities Status COMPLETED Phase NA
NCT02873598 A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02872831 Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle Status WITHDRAWN Phase NA
NCT02869802 Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis Status RECRUITING Phase N/A
NCT02868632 Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1
NCT02854072 A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients Status UNKNOWN Phase PHASE3
NCT02851381 Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer Status WITHDRAWN Phase NA
NCT02843945 Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source Status RECRUITING Phase PHASE1/PHASE2
NCT02841800 Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis Status COMPLETED Phase NA
NCT02841436 A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer Status COMPLETED Phase NA
NCT02838836 Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers Status RECRUITING Phase N/A
NCT02830724 Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT02822716 Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy Status TERMINATED Phase NA
NCT02818907 Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable Status COMPLETED Phase NA
NCT02811666 Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers Status UNKNOWN Phase NA
NCT02810652 Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection Status COMPLETED Phase NA
NCT02791334 A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT02777710 Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers Status COMPLETED Phase PHASE1